| in this issue... |
|
HIPAA Countdown
|
| Around BIDMC |
| Calendar |
| In
the News |
| Moments That
Matter |
| Logo Returns |
| Employee
Service Awards |
|
Physician Network
Selects BIDMC
|
| Greg
Ciottone, M.D. Discusses Sept. 11 |
Past
Issues |
|
September
11:
One Year Later
Upon this first anniversary of Sept. 11, 2001, we reflect not only
on what we lost, but on the extraordinary responses that showed
Americans’ compassion and strength. Beth Israel Deaconess
staff are among those making a difference — both by helping
people affected by Sept. 11 and by taking part in national efforts
to address possible future attacks.
Writing the book on disaster management: Greg Ciottone,
M.D., director of BIDMC’s division of international disaster
and emergency medicine, has been named an implementing partner of
the United Nations Disaster Management Training Program. His first
assignment: Write a training module for foreign countries on how
to deal with terrorist attacks. This is a joint project with the
World Health Organization.
Ciottone dealt with the aftermath of terrorism firsthand. As Commander
of a federal Disaster Medical Assistance Team, Ciottone was called
into service Sept. 11 moments after the first tower fell. See
his story and photos.
Researching anthrax vaccines: BIDMC researchers
Lewis Cantley, Ph.D., and Benjamin Turk, Ph.D., have received a
$100,000 grant from the National Science Foundation (NSF) to find
inhibitors of “anthrax lethal factor,” the deadly toxin
produced by anthrax bacteria. The grant is one of a series the NSF
awarded for academic research prompted by last fall’s terrorist
attacks and anthrax outbreaks.
“Inhalational anthrax is nearly always fatal unless antibiotic
treatment begins early in the course of the disease,” says
Cantley. “There is therefore an urgent need for novel agents
to treat the disease.”
Helping people heal: BIDMC’s Center for Violence
Prevention and Recovery is providing counseling for Sept. 11 victims
and their partners and families, as well as crisis responders and
their families. Funded by a $149,000 grant from the Massachusetts
Office of Victim Assistance, free services include:
- Individual or family counseling for trauma related to Sept. 11
- Workshops to reduce symptoms of secondary trauma
- Legal and financial advocacy
Also planned: Group support sessions for victims’ family members.
Information: Lisa Tieszen, M.A., L.I.C.S.W., at (66)7-8241 or Amy
Brow, M.S.W., (66)7-2663
-Valerie Hope Goldstein
Published monthly for the people of
Beth Israel Deaconess Medical Center to build community, communicate
direction, foster pride and recognize accomplishments.
Produced by Beth Israel Deaconess communications, (63)2-8052
director, internal communications:
Cindy ReVelle
managing editor:
Valerie Hope Goldstein
contributing writer:
Sai Haridoss, Lisa Linden, Anna Kalluri
layout & design:
Jane N. Hayward, Jennifer McGrath
web design:
Jim Dwyer, Jennifer McGrath
contributing photographers
Jane Bell, Bruce Wahl
© CareGroup, Inc., Boston, MA, USA, 2002. All rights reserved. Material
may be reproduced only with the express written consent of communications.
|
|
|
|
BIDMC
Takes Science By Storm

If you were talking about hockey,
it would be a hat trick; in the world of thoroughbred horse racing,
the Triple Crown. For researchers at Beth Israel Deaconess, the triple
play was studies published in three back-to-back issues of Science,
a prestigious journal recognized internationally for its influential,
peer-reviewed content. Science is published weekly by the American
Academy for the Advancement of Science. The three articles were written
by BIDMC senior scientists Christopher Walsh, M.D., Ph.D., neurology;
Joel Elmquist, D.V.M., Ph.D., endocrinology; and Bradford Lowell, M.D.,
Ph.D., endocrinology, and appeared in Science on July 19, July
26 and Aug. 2, respectively. The studies sparked stories in media outlets
in the U.S. and abroad.
The study out of Walsh’s laboratory, led by research fellow Anjen
Chenn, M.D., Ph.D., identified a new function of a gene known as beta
catenin. This discovery helps to explain why the human brain is so much
larger than the brains of other species, a finding that could help researchers
and clinicians in understanding brain development as well as brain disorders.
The other two studies featured in Science described new discoveries
in endocrinology that illuminate the role the brain plays in obesity
and weight gain. The first, out of Elmquist’s lab and led by Lora
Heisler, Ph.D., helps explain how the diet drug fen-phen — banned
several years ago following the development of cardiac side effects
in some patients — works to promote weight loss. This discovery
could eventually lead to the development of a new anti-obesity drug
as effective as fen-phen that does not cause cardiac problems.
The study led by Eric Bachman, M.D., Ph.D., in Lowell’s lab, helps
explain a process known as diet-induced thermogenesis, an inherent form
of “heat production” that helps the body burn excess calories
and thereby keep weight stabilized. This discovery, too, could eventually
help researchers in developing anti-obesity therapies.
Chief Academic Officer Jeffrey S. Flier, M.D., points out the distinct
honor of BIDMC having three studies published consecutively in Science.
“Biomedical research is an extremely important part of the medical
center’s mission, and accomplishments such as this speak to our
growing strength as a leader among the world’s biomedical research
institutions,” he says.
“These three studies represent just some of the terrific work
being done by hundreds of basic scientists at BIDMC.”
- Bonnie Prescott
What Is A Peer-Reviewed Journal?
In the world of science and medicine, publishing a paper in a "peer
reviewed" journal is considered the "gold standard" of
credibility. "Peer review" means that the paper has been read
and evaluated by a group of other scientists, who then critique and
comment on the logic, methods and reproducibility of the scientific
experiment.
New Journal Publication Web Site Available
To
see a listing of current journal publications by BIDMC faculty, go to
the bottom of the Carl J. Shapiro Institute’s Web page (http://research.caregroup.org/Institute)
and click on “BIDMC Research Publications” (or access the
site directly by going to http://research.caregroup.org/Data/Pubs.asp).
The Research Publications Web site draws from Current Contens and PubMED
and is updated monthly. It includes abstracts (where available), plus
information about authorship and how to access the specific publication.
Research scientists and other faculty at BIDMC can use the site to gain
a broader appreciation of the vast and varied research conducted at
BIDMC, and individuals outside the institution – ranging from
potential house staff candidates, to individuals being recruited to
BIDMC – who may be interested in research or clinical opportunities
at BIDMC can understand more fully the extent and sophistication of
our research programs. The site was created by the Carl J. Shapiro in
collaboration with Margo Coletti, director of medical libraries, Jay
Daly, medical librarian, and Stephen Berry, director of academic computing.
return to top of page
|